AU2014201660B2 — Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
Assigned to Universite Victor Segalen Bordeaux 2 · Expires 2015-09-03 · 11y expired
What this patent protects
The present invention relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for s example of infantile hemangiomas, The beta blocker may be a non selective beta-blocker, for example propranolol. The present invention provides an a…
USPTO Abstract
The present invention relates the use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas, for s example of infantile hemangiomas, The beta blocker may be a non selective beta-blocker, for example propranolol. The present invention provides an alternative to the known compounds, e.g. corticosteroids, interferon or vincristine, generally used for the treatment of hemangiomas.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.